Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
5.53 +0.03 / +0.55%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.53 +0.0011 / +0.02%
Volume: 30.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues33.9M14.8M36.6M16.4M
Depreciation And Amortization412.0K1.1M1.0M2.2M
Operating ExpensesGross Income--13.8M----
General Expenses38.6M43.8M54.1M52.5M
Research And Development30.7M35.7M42.8M37.8M
Total Operating Expenses39.0M44.9M55.1M54.7M
Non-Operating ExpensesOperating Income-5.1M-30.0M-18.6M-38.3M
Interest Expense On Debt4.6M4.6M4.5M4.5M
Other Expenses151.0K113.0K110.0K356.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.5M-34.4M-22.9M-42.4M
Minority Interest-219.0K-327.0K-123.0K-208.0K
Net Income-9.7M-34.8M-22.8M-42.6M
Shares To Calculate EPSShares To Calculate EPS106.7M107.1M110.0M112.4M
Shares To Calculate EPS Diluted106.7M107.1M110.0M112.4M
Earnings Per ShareEPS-$0.09-$0.32-$0.21-$0.38
EPS Diluted-$0.09-$0.32-$0.21-$0.38